HB1811 amends the Illinois Controlled Substances Act section governing access to the Prescription Monitoring Program (PMP), with a focus on how pharmacy and health-record systems connect to the program and how Illinois shares PMP data with other states. The bill preserves the Department of Human Services’ authority to set technical, security, and privacy requirements for integrations, while reinforcing that the Department may not force providers, pharmacies, or electronic health record systems to use a particular vendor or connection method.
The bill also adds a new interstate data-sharing requirement: any agreement with another state must be mutual. Illinois would only share PMP data if the other state gives equal access to its own data to Illinois authorized users, licensed health care entities, and application vendors, regardless of how they connect to that state’s PMP. The bill is effective immediately.
Impact
HB1811 would amend Section 316.1 of the Illinois Controlled Substances Act, affecting the state Prescription Monitoring Program and the entities that integrate with it, including electronic health record systems, pharmacy dispensing systems, pharmacy management systems, and certified health IT modules. It would not broadly change controlled-substance law, but it would tighten the rules around vendor access, customer choice, memoranda of understanding, and interstate data-sharing arrangements. In practice, the bill would condition Illinois participation in cross-state PMP sharing on reciprocal access and could affect how DHS negotiates or maintains data-sharing agreements with other states and integration vendors.
Sentiment
Based on the bill text and the absence of recorded committee testimony or votes, the available record suggests a policy-oriented, administrative measure rather than a highly partisan proposal. The bill appears aimed at protecting Illinois users’ access choices and ensuring reciprocity in interstate PMP data exchange, which are typically framed as operational and fairness concerns. Because there are no transcripts or vote results provided, there is no documented public sentiment from committee debate in the available materials.
Contention
The main points of potential contention are vendor neutrality, state control over data integration, and the reciprocity requirement for interstate sharing. Health care entities, pharmacies, and software vendors may be attentive to the bill’s restrictions on data storage, caching, resale, analysis, and audit access, as well as the Department’s ability to disable integrations or require memoranda of understanding. Another likely issue is whether the mutual-access standard could limit Illinois’ ability to participate in interstate PMP networks if other states do not offer equivalent access to all Illinois-authorized users and vendors.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Prescriptions for testosterone not allowed to be transmitted or reported within the prescription drug monitoring database and removes from the records all existing information concerning prior testosterone prescriptions.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a sixty-day (60) supply may be dispensed at any one time.
Increases the maximum fill for non-opioid, non-narcotic controlled substances found in schedule II, so that a ninety-day (90) supply may be dispensed at any one time.